Hydrogen Sulfide Delays LPS-Induced Preterm Birth in Mice via Anti-Inflammatory Pathways.

Hydrogen Sulfide Delays LPS-Induced Preterm Birth in Mice via Anti-Inflammatory Pathways.
复制标题

硫化氢通过抗炎途径延迟 LPS 诱导的小鼠早产

DOI:
10.1371/journal.pone.0152838
复制
发表时间:
2016
期刊:
影响因子:
3.7
通讯作者:
Ni X
Ni X
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Liu W;Xu C;You X;Olson DM;Chemtob S;Gao L;Ni X

文献摘要

被引文献

相似文献

孕妇早产的一个主要原因是羊膜内感染,这是由炎症过程介导的。硫化氢(H2S)是一种气态递质,与炎症反应有关。我们试图通过脂多糖(LPS)诱导的早产小鼠模型来研究H2S是否影响感染性早产。妊娠14.5天,腹腔注射LPS (0.4 mg/kg) 2次,诱导早产。LPS显著增加子宫内白细胞浸润,刺激子宫肌层促炎因子白细胞介素1β (IL-1β)、IL-6、肿瘤坏死因子α (TNF-α)、CCL2、CXCL15的表达。NaHS (i.p.)的使用以剂量依赖的方式延迟LPS诱导的分娩发生。NaHS可阻止白细胞向宫内组织浸润,抑制子宫肌层中促炎细胞因子的产生,并降低母体循环中这些细胞因子的水平。H2S还降低了肌层中脂多糖激活的细胞外信号调节激酶(ERK) 1/2/核因子(NF)-κB信号通路。该研究为H2S在减轻炎症中的作用提供了新的体内证据,并为感染相关性早产提供了潜在的新治疗策略。
A major cause of preterm labor in pregnant women is intra-amniotic infection, which is mediated by an inflammatory process. Hydrogen sulfide (H2S), a gaseous transmitter, has been implicated to be involved in inflammatory responses. We sought to investigate whether H2S affects infectious preterm birth using the mouse model of lipopolysaccharides (LPS)-induced preterm birth. Administration of LPS at 0.4 mg/kg with two injections intraperitoneally (i.p.) on gestational day 14.5 induced preterm labor. LPS significantly increased leukocyte infiltration in uterus, stimulated the expression of pro-inflammatory cytokines interleukin 1β (IL-1β), IL-6, tumor necrosis factor α (TNF-α), CCL2 and CXCL15 in myometrium. Administration of NaHS (i.p.) delayed the onset of labor induced by LPS in a dose-dependent manner. NaHS prevented leukocyte infiltration into intrauterine tissues and inhibited the production of pro-inflammatory cytokines in myometrium and decreased the levels of these cytokines in maternal circulation. H2S also decreased LPS-activated extracellular signal-regulated kinase (ERK) 1/2/ nuclear factor (NF)-κB signaling pathways in myometrium. This study provides new in vivo evidence for the roles of H2S in attenuating inflammation, and a potential novel therapeutic strategy for infection-related preterm labor.